Progrès, Commission

Progrès au service de la santé osseuse: la Commission européenne approuve les biosimilaires du Denosumab de Biocon Biologics

Published on 08/07/2025 at 18:03 | prnewswire.co.uk

Biocon Biologics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom India

en | boerse | 67990437 |